Stereotaxis Inc. (NSDQ:STXS) reported strong fourth-quarter and year-end sales, helping the company narrow losses nearly 38 percent in 2009.
The St. Louis, Mo.-based cardiology instrument control system maker reported a net loss of $6.7 million on $14 million in sales during the three months ended Dec. 31, 2009, compared to a loss of $7.5 million on $12 million in sales during the comparable period in 2008.
For the full year, Stereotaxis reported a $27.5 million net losses on $51 million in sales, compared to a $44 net loss on $40 million in sales during 2008.
The firm also provided sales guidance for 2010, estimating total revenue growth to be in the mid-20 percent range.